Horizon / Plein textes La base de ressources documentaires de l'IRD

IRD

 

Publications des scientifiques de l'IRD

Bertout S., Drakulovski P., Kouanfack C., Krasteva D., Ngouana T., Dunyach-Remy C., Dongtsa J., Aghokeng Fobang Avelin, Delaporte Eric, Koulla-Shiro S., Reynes J., Mallie M. (2013). Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients. Clinical Microbiology and Infection, 19 (8), 763-769. ISSN 1198-743X

Accès réservé (Intranet IRD) Demander le PDF

Lien direct chez l'éditeur doi:10.1111/1469-0691.12019

Titre
Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients
Année de publication2013
Type de documentArticle référencé dans le Web of Science WOS:000321761900023
AuteursBertout S., Drakulovski P., Kouanfack C., Krasteva D., Ngouana T., Dunyach-Remy C., Dongtsa J., Aghokeng Fobang Avelin, Delaporte Eric, Koulla-Shiro S., Reynes J., Mallie M.
SourceClinical Microbiology and Infection, 2013, 19 (8), p. 763-769. ISSN 1198-743X
RésuméCryptococcus neoformans is the most common cause of meningitis amongst adult Africans with HIV/AIDS. The widespread use of fluconazole may lead to the emergence of isolates with reduced susceptibility. We studied C.neoformans isolates from HIV-infected patients with cryptococcal meningitis. Genotyping and antifungal testing were performed to assess the genetic diversity, occurrence of mixed infections and in vitro activity of antifungal agents. Isolates were recovered from cerebrospinal fluid prior to systemic antifungal treatment. Six isolates were studied for each sample (a total of 114 isolates from 19 patients). Serotyping was performed via LAC 1 and CAP 64 gene amplification and genotyping was performed using phage M13 core, (GACA)(4) and (GTG)(5) primers and restriction polymorphism analysis of the URA5 gene. Susceptibilities for amphotericin B, flucytosine, fluconazole, voriconazole and posaconazole were tested by the Sensititre YeastOne (R) method. All strains were identified as C.neoformans var. grubii serotype A. We identified nine major genotypes. Up to two genotypes were identified in the same sample. None of the isolates were resistant to the studied drugs. However, 13 of 114 strains exhibited a reduced susceptibility to fluconazole and 13 of 114 strains exhibited a reduced susceptibility to flucytosine. No correlation was found between the genotype and susceptibility. This study confirms the prevalence of C.neoformans serotype A in Cameroon. Two genotypes may be responsible for a single episode of cryptococcosis. The possibility of mixed infection and diminished susceptibility to fluconazole or flucytosine must be considered for the management of cryptococcosis.
Plan de classementEntomologie médicale / Parasitologie / Virologie [052] ; Sciences fondamentales / Techniques d'analyse et de recherche [020]
Descr. géo.CAMEROUN
LocalisationFonds IRD [F B010060561]
Identifiant IRDfdi:010060561
Lien permanenthttp://www.documentation.ird.fr/hor/fdi:010060561

Export des données

Disponibilité des documents

Télechargment fichier PDF téléchargeable

Lien sur le Web lien chez l'éditeur

Accès réservé en accès réservé

HAL en libre accès sur HAL


Accès aux documents originaux :

Le FDI est labellisé CollEx

Accès direct

Bureau du chercheur

Site de la documentation

Espace intranet IST (accès réservé)

Suivi des publications IRD (accès réservé)

Mentions légales

Services Horizon

Poser une question

Consulter l'aide en ligne

Déposer une publication (accès réservé)

S'abonner au flux RSS

Voir les tableaux chronologiques et thématiques

Centres de documentation

Bondy

Montpellier (centre IRD)

Montpellier (MSE)

Cayenne

Nouméa

Papeete

Abidjan

Dakar

Niamey

Ouagadougou

Tunis

La Paz

Quito